Homepage - Ophthalmology Advisor
WEBBy Alan P. Lyss, MD. Factors preventing more widespread use of biosimilars in oncology include the cost and complexity of biosimilar development, oncologists’ lack of knowledge about biosimilars, and the fact that interactions between payers, manufacturers, and pharmacy benefit managers can sometimes drive up the cost of biosimilars.
Heavy Drinking Can Damage Every Part of the Eye
WEBJun 24, 2022 · Those who drink heavily can develop peripheral neuropathy, which in turn may decrease corneal sensitivity, masking the real severity of dry eye. Researchers behind that study say their findings “indicate that controlling alcohol consumption may help to reduce [dry eye] prevalence.” 9. Sight-Threatening Diseases.
PRK Enhancement Improves Visual Acuity, Refractive Outcomes
WEBPhotorefractive keratectomy (PRK) enhancement following primary PRK surgery is associated with both improved refractive outcomes and visual acuity, according to research published in Ophthalmology and Therapy.. Researchers conducted a retrospective analysis of patients who underwent wavefront-optimized PRK enhancement following PRK refractive surgery at a single center to analyze their visual ...
Trifocal EDOF Lens Implants Have Better Outcomes Than …
WEBJun 25, 2024 · Intraindividual monocular defocus curves differed significantly at defocus levels of 0.0 D (P =.005) and between -1.5 and -4.0 D (P <.001), with the trifocal EDOF IOL showing a broader curve and a minor second peak at -2.5 D (0.18 logMAR).The depth of field differences at 0.2 logMAR corresponded to defocus levels of -1.89D for the trifocal EDOF and -1.18 D for the monofocal EDOF IOL.
Review: Atropine 0.05% May Be Optimal Dose to Slow Myopia
WEBDec 22, 2020 · Researchers concluded that the data confirms atropine’s role in managing the progression of myopia. Further, they affirmed its effectiveness may be closely dose-related, with 0.05% as optimal. Reference. Zhao C, Cai C, Ding Q, Dai H. Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis.
Nerve Block for Supraorbital Neuralgia Effective for Both Diagnosis …
WEBJun 17, 2020 · Approximately 8% of subjects in a recent thyroid eye disease study population of 1126 developed symptoms of supraorbital neuralgia, often describing the pain as burning, throbbing, or similar to a nail “driven through the head.”
Papilledema or Pseudopapilledema? Sharpen Your Image …
WEBFigure 9. These OCT volume scans demonstrate a reduction in the overall volume of the left optic nerve changes at a follow up visit. Less edema is noted in the left after treatment with a unilateral optic nerve sheath fenestration (ONSF) for high grade papilledema in the clinical setting of an afferent pupillary defect and monocular reduction in vision (image on …
Revakinagene Taroretcel Reduces Progression of Macular …
WEBAug 2, 2023 · Participants diagnosed with MacTel with ellipsoid zone (EZ; inner segment/outer segment [IS/OS]) loss between 0.16 and 2.00 mm 2 were randomly assigned 1:1 to NT-501 or sham treatment in the study eye (120 participants in NTMT-03-A and 119 in NTMT-03-B were included). Both the evaluators and participants were masked to the treatment assignments, while the ophthalmologists and clinic ...
Differentiation of Diabetic Retinal Disease vs Other Retinopathies
WEBAug 6, 2021 · Vascular retinopathies, such as diabetic retinopathy (DR) and retinal vein occlusion are common causes of vision loss and blindness in the US and worldwide. Although DR is the most common retinal vascular disease (RVD), not all RVDs are associated with diabetes. Retinal vascular alteration and damage can be secondary to some primary eye conditions, such as retinal telangiectasia in Coats ...
Restoring the Retina: Coming Advancements to Repair Structure …
WEBFeb 16, 2021 · Retinal implants capture light and stimulate secondary neurons that have remained in the retina, such as ganglion cells and bipolar cells, which then send signals to the brain through the optic nerve. “Patients who get a retinal implant will see at least flashes of light,” says Gislin Dagnelie, PhD, associate professor of ophthalmology at ...